Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 755-758

  Whyte, M ^a   Hubbard, R ^a   Meliconi, R ^a   Whidborne, M ^a   Eaton, V ^a   Bingle, C ^a   Timms, J ^a   Duff, G ^a   Facchini, A ^a   Pacilli, A ^a   Fabbri, M ^a   Hall, I ^a   Britton, J ^a   Johnston, I ^a   Di Giovine, F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM;

EID: 0033837130     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9909053     Document Type: Article

References (23)

1. Interstitial lung diseases of unknown cause: 1. Disorders characterized by chronic inflammation of the lower respiratory tract
2. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?
3. An analysis of linkage disequilibrium in the interleukin-1 gene cluster using a novel method for grouping multialleleic markers
4. Genetics of tumour necrosis factor-α in autoimmune, infectious and neoplastic diseases
5. Interleukin-1 receptor antagonist
6. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment
7. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
8. Single base polymorphism in the human tumour necrosis alpha (TNF-α) gene detectable by Nco 1 restriction of PCR product
9. Tumour necrosis haplotypes and asthma
10. Tumor necrosis factor-α gene polymorphism in chronic bronchitis
11. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
12. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis
13. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridisation
14. Meta-analysis
15. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease
16. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis
17. Generation of a transgenic mouse with lung-specific over-expression of the human interleukin-1 receptor antagonist protein
18. Interleukin-1 receptor antagonist prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
19. Allele 2 of the interleukin-1 receptor antagonist gene polymorphism is associated with reduced expression of interleukin-1 receptor antagonist in ulcerative colitis
20. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis
21. Expression of tumor-necrosis-factor-alpha in cryptogenic fibrosing alveolitis
22. Expression of a TNF-α transgene in murine lung causes lymphocytic and fibrosing alveolitis: A mouse model of progressive pulmonary fibrosis
23. Effects of a polymorphism in the human TNF-α promoter on transcriptional activation